BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1741620)

  • 21. Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers.
    Mureev S; Kushnir S; Kolesnikov AA; Breitling R; Alexandrov K
    Mol Biochem Parasitol; 2007 Oct; 155(2):71-83. PubMed ID: 17658188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional cloning as a means to identify Leishmania genes involved in drug resistance.
    Clos J; Choudhury K
    Mini Rev Med Chem; 2006 Feb; 6(2):123-9. PubMed ID: 16472181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania.
    Mukherjee A; Boisvert S; Monte-Neto RL; Coelho AC; Raymond F; Mukhopadhyay R; Corbeil J; Ouellette M
    Mol Microbiol; 2013 Apr; 88(1):189-202. PubMed ID: 23421749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
    Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
    Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct overexpression of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential detoxification of different oxidants in arsenite-resistant Leishmania amazonensis with and without DNA amplification.
    Lin YC; Hsu JY; Chiang SC; Lee ST
    Mol Biochem Parasitol; 2005 Jul; 142(1):66-75. PubMed ID: 15907561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistant Leishmania.
    Singh AK; Liu HY; Lee ST
    Mol Biochem Parasitol; 1994 Jul; 66(1):161-4. PubMed ID: 7984181
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug resistance analysis by next generation sequencing in Leishmania.
    Leprohon P; Fernandez-Prada C; Gazanion É; Monte-Neto R; Ouellette M
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):26-35. PubMed ID: 25941624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
    Chang CF; Bray T; Whiteley JM
    Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics. Leishmania exploit sex.
    Miles MA; Yeo M; Mauricio IL
    Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genetic manipulation and the study of the protozoan parasite Leishmania].
    Cortázar TM; Walker J
    Biomedica; 2004 Dec; 24(4):438-55. PubMed ID: 15678807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the parasite Leishmania in the post-genomic era].
    Ouellette M; Olivier M; Sato S; Papadopoulou B
    Med Sci (Paris); 2003 Oct; 19(10):900-9. PubMed ID: 14612998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular identification of Leishmania: development and application of DNA probes in Tunisia].
    Guizani I; Ben Hamouda A; Jedidi S; Dellagi K; Ben Ismaïl R
    Arch Inst Pasteur Tunis; 1994; 71(3-4):439-46. PubMed ID: 8801839
    [No Abstract]   [Full Text] [Related]  

  • 34. Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador.
    Katakura K; Kawazu SI; Sanjyoba C; Naya T; Matsumoto Y; Ito M; Nagakura K; Aikawa M; Hashiguchi Y
    Tokai J Exp Clin Med; 1998 Dec; 23(6):393-9. PubMed ID: 10622637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time PCR to assess the Leishmania load in Lutzomyia longipalpis sand flies: screening of target genes and assessment of quantitative methods.
    Bezerra-Vasconcelos DR; Melo LM; Albuquerque ÉS; Luciano MC; Bevilaqua CM
    Exp Parasitol; 2011 Nov; 129(3):234-9. PubMed ID: 21864530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cos-Seq: A High-Throughput Gain-of-Function Screen for Drug Resistance Studies in Leishmania.
    Potvin JE; Leprohon P; Gazanion E; Sharma M; Fernandez-Prada C; Ouellette M
    Methods Mol Biol; 2019; 1971():141-167. PubMed ID: 30980302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene amplification in cultured cells.
    Schimke RT
    J Biol Chem; 1988 May; 263(13):5989-92. PubMed ID: 3283115
    [No Abstract]   [Full Text] [Related]  

  • 38. More surprises from Kinetoplastida.
    Donelson JE; Gardner MJ; El-Sayed NM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2579-81. PubMed ID: 10077550
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene amplification and drug resistance.
    Fox M
    Nature; 1984 Jan 19-25; 307(5948):212-3. PubMed ID: 6694725
    [No Abstract]   [Full Text] [Related]  

  • 40. Ways with drug resistance.
    Nature; 1984 Sep 20-26; 311(5983):208. PubMed ID: 6482949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.